Epithelial recurrent erosion dystrophy

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

1 event
May 1996

Ocuflox Ophthalmic Solution: FDA approved

Treatment of bacterial corneal ulcers.

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

Ocuflox Ophthalmic Solution

Allergan, Inc.

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Ocuflox Ophthalmic Solution

(Ofloxacin)Orphan drug

Allergan, Inc.

Quinolone Antimicrobial [EPC]

Approved May 1996FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Epithelial recurrent erosion dystrophy.
Search all trials →
Search clinical trials for Epithelial recurrent erosion dystrophy

Recent News & Research

No recent news articles indexed yet for Epithelial recurrent erosion dystrophy.
Search PubMed for Epithelial recurrent erosion dystrophy

Browse all Epithelial recurrent erosion dystrophy news →

Specialist Network

No specialists currently listed for Epithelial recurrent erosion dystrophy.

View all Epithelial recurrent erosion dystrophy specialists →

Quick Actions